Gottlieb, an MD, was a senior advisor at both CMS and FDA (2002-2004). He is currently a partner at New Enterprise Associates, a top-tier VC firm, and also a managing director at investment banking firm T.R. Winston. As a conservative, he is associated with the American Enterprise Institute. Gottlieb is a recurring op ed writer for Forbes (here) and for the Wall Street Journal (e.g. here, on FDA, August 2016; and here, on Obamacare, December 2016).
See the Reuters story, here. Gottlieb has 35K followers on Twitter, here.
I give him 3:1 odds for the nomination.
- December 9, STAT, here. (subscription)
- December 12, Fast Company, here.
- December 13, FierceBiotech, here.